SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-002745
Filing Date
2019-04-18
Accepted
2019-04-18 14:42:45
Documents
46
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT plsi-10q_083116.htm 10-Q 231051
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 6502
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 6492
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 3090
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 3071
  Complete submission text file 0001387131-19-002745.txt   2199101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20160831.xml EX-101.INS 272080
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20160831.xsd EX-101.SCH 32390
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20160831_cal.xml EX-101.CAL 32242
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20160831_def.xml EX-101.DEF 153237
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20160831_lab.xml EX-101.LAB 235775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20160831_pre.xml EX-101.PRE 188489
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

IRS No.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 333-167275 | Film No.: 19755594
SIC: 1311 Crude Petroleum & Natural Gas